SCHEMBL7380533

SCHEMBL7380533

CN(CC(=O)O)C(=O)CCCc1ccncc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.45
KMT2A Q03164 1/20 0.43
USP2 O75604 1/20 0.43
TSHR P16473 1/20 0.43
HDAC3 O15379 1/20 0.42
MAPK1 P28482 1/20 0.42
ADRA1A P35348 1/20 0.42
HDAC4 P56524 1/20 0.42
SLC6A3 Q01959 1/20 0.42
HDAC1 Q13547 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
FFAR1 O14842 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206701 0.84 RAB9A (0.45) ALOX5KMT2AUSP2TSHRHDAC3
SCHEMBL7380546 0.83 ALOX5 (0.48) ALOX5KMT2AMAPK1SMN1; SMN2KDM4E
SCHEMBL10568746 0.81 SMN1; SMN2 (0.50) ALOX5TSHRHDAC3HDAC1SMN1; SMN2
SCHEMBL7992967 0.78 ALOX5 (0.56) ALOX5KMT2AHDAC3MAPK1ADRA1A
SCHEMBL1624984 0.78 HDAC3 (0.67) HDAC3MAPK1ADRA1AHDAC4SLC6A3
SCHEMBL7992970 0.77 SMN1; SMN2 (0.42) ALOX5HDAC3MAPK1ADRA1AHDAC4
Hydrochloric Acid SCHEMBL6644828 0.77 HDAC3 (0.64) HDAC3MAPK1ADRA1AHDAC4SLC6A3
SCHEMBL7374914 0.76 KMT2A (0.72) ALOX5KMT2AHDAC3MAPK1ADRA1A
SCHEMBL2201636 0.75 ALOX5 (0.55) ALOX5KMT2AHDAC3MAPK1ADRA1A
SCHEMBL11958358 0.74 KMT2A (0.51) KMT2AUSP2SMN1; SMN2FFAR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0880511-A4 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1999-06-16 EP disclosed
EP-0880511-A1 INTEGRIN RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-12-02 EP disclosed
WO-1997026250-A1 INTEGRIN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1997-07-24 WO disclosed